These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10888414)

  • 1. Indications and complications of intravenous devices for chemotherapy.
    Freytes CO
    Curr Opin Oncol; 2000 Jul; 12(4):303-7. PubMed ID: 10888414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications of central venous and indwelling catheterization].
    Douard MC; Desruennes E; Kriegel I; Blot F
    Rev Prat; 2006 Jun; 56(12):1281-9. PubMed ID: 16948214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of indwelling venous access devices in patients with gynecologic malignancies.
    Estes JM; Rocconi R; Straughn JM; Bhoola S; Leath CA; Alvarez RD; Kilgore LC; Huh WK
    Gynecol Oncol; 2003 Dec; 91(3):591-5. PubMed ID: 14675682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of indwelling venous access devices in cancer patients.
    Eastridge BJ; Lefor AT
    J Clin Oncol; 1995 Jan; 13(1):233-8. PubMed ID: 7799025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous access: related problems in oncology.
    Viot M
    Int J Antimicrob Agents; 2000 Oct; 16(2):165-8. PubMed ID: 11053802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A rare complication of port catheter].
    Kıral N; Saraç G; Yüksel T; Salepçi B; Cağlayan B
    Tuberk Toraks; 2010; 58(2):177-80. PubMed ID: 20865571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
    Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications.
    Kulkarni S; Wu O; Kasthuri R; Moss JG
    Cardiovasc Intervent Radiol; 2014 Aug; 37(4):990-1008. PubMed ID: 24218174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
    Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
    Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.
    Mori Y; Nagayama S; Kawamura J; Hasegawa S; Tanaka E; Okabe H; Takeuchi M; Sonobe M; Matsumoto S; Kanai M; Muto M; Chiba T; Sakai Y
    Int J Clin Oncol; 2016 Jun; 21(3):474-82. PubMed ID: 26507141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placement and management of long-term central venous access catheters and ports.
    Denny DF
    AJR Am J Roentgenol; 1993 Aug; 161(2):385-93. PubMed ID: 8333382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic complications related to indwelling central venous catheters in children.
    Freytes CO
    Curr Opin Oncol; 2003 Jul; 15(4):289-92. PubMed ID: 12874506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of infection and occlusion associated with vascular access devices.
    Rumsey KA; Richardson DK
    Semin Oncol Nurs; 1995 Aug; 11(3):174-83. PubMed ID: 7481145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.